Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Berwyn, PA
SEC filing record 1 source field available
Fiscal year end
31 December
Virpax Pharmaceuticals, Inc. has filed 278 SEC EDGAR filings since 05 Apr 2018

SEC filing history

Showing 76-100 of 278 matching filings.

Per page
25
Current page
4
DEFA14A File 001-40064

ADDITIONAL PROXY MATERIALS

Filing date
08 Jul 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-40064

CURRENT REPORT

Filing date
08 Jul 2024
Reporting date
05 Jul 2024
Next action
Verify source filing
8-K File 001-40064

CURRENT REPORT

Filing date
03 Jul 2024
Reporting date
28 Jun 2024
Next action
Verify source filing
ARS File 001-40064

FORM ARS

Filing date
12 Jun 2024
Reporting date
31 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-40064

PROXY STATEMENT

Filing date
12 Jun 2024
Reporting date
29 Jul 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-92861

SCHEDULE 13G

Filing date
23 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-40064

CURRENT REPORT

Filing date
17 May 2024
Reporting date
14 May 2024
Next action
Verify source filing
424B4 File 333-278796

PROSPECTUS

Filing date
16 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-278796

EFFECT filing

Filing date
14 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
14 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-278796

AMENDMENT NO. 3 TO FORM S-1

Filing date
13 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-40064

CURRENT REPORT

Filing date
13 May 2024
Reporting date
13 May 2024
Next action
Verify source filing
10-Q File 001-40064

QUARTERLY REPORT

Filing date
13 May 2024
Reporting date
31 Mar 2024
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
09 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
03 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
03 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-40064

CURRENT REPORT

Filing date
02 May 2024
Reporting date
02 May 2024
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
02 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-278796

AMENDMENT NO. 2 TO FORM S-1

Filing date
02 May 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-40064

CURRENT REPORT

Filing date
30 Apr 2024
Reporting date
30 Apr 2024
Next action
Verify source filing
S-1/A File 333-278796

AMENDMENT NO. 1 TO FORM S-1

Filing date
26 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 333-278796

UPLOAD filing

Filing date
23 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1 File 333-278796

REGISTRATION STATEMENT

Filing date
18 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-278522

REGISTRATION STATEMENT

Filing date
05 Apr 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-40064

CURRENT REPORT

Filing date
03 Apr 2024
Reporting date
02 Apr 2024
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .